John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 43,900 shares at $26.36 ($1.2M) on 2024-07-23, disclosed to the SEC on 2024-07-25.
Scheduled sale ($1.2M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.03 | 5,530 | $138K | 12.0% |
| 2 | $25.03 | 5,530 | $138K | 12.0% |
| 3 | $26.36 | 7,924 | $209K | 18.1% |
| 4 | $26.36 | 7,924 | $209K | 18.1% |
| 5 | $27.10 | 8,446 | $229K | 19.8% |
| 6 | $27.10 | 8,446 |
| $229K |
| 19.8% |
| 7 | $27.87 | 100 | $3K | 0.2% |
| Total | $26.31 avg | 43,900 | $1.2M | 100% |
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |